Remepy
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
$36MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
Fabless semiconductor company building connectivity chips for hyperscale, edge, and AI data centers
Builds perception systems for Physical AI operating in complex environments